Header Logo

Connection

KENNETH R HESS to Receptor, IGF Type 1

Back to Details
This is a "connection" page, showing publications KENNETH R HESS has written about Receptor, IGF Type 1.
KENNETH R HESS
Connection Strength
0.028
Receptor, IGF Type 1
  1. The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab. Oncologist. 2015 Jul; 20(7):737-41.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.